SCHEMBL787222

SCHEMBL787222

c1ccc(-c2ccc(-c3cccc4c3oc3c(-c5ccc6[nH]c7ccc(-c8cccc9c8oc8c(-c%10ccc(-c%11ccccc%11)cc%10)cccc89)cc7c6c5)cccc34)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
ALDH1A1 P00352 3/20 0.40
BRD4 O60885 3/20 0.40
BRD2 P25440 2/20 0.40
BRD3 Q15059 2/20 0.40
CDK4 P11802 5/20 0.40
CCND1 P24385 5/20 0.40
PRKDC P78527 5/20 0.39
PIK3CD O00329 2/20 0.39
PIK3CA P42336 2/20 0.39
PIK3CB P42338 2/20 0.39
PIK3CG P48736 2/20 0.39
KDM4E B2RXH2 2/20 0.39
PDE2A O00408 1/20 0.39
PIK3C2A O00443 1/20 0.39
PIK3R2 O00459 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL786991 0.98 ALOX5 (0.46) ALOX5SMN1; SMN2HPGDMAPK1HTT
SCHEMBL788435 0.97 AHR (0.43) ALOX5SMN1; SMN2HPGDMAPK1HTT
SCHEMBL788287 0.95 AHR (0.44) ALOX5SMN1; SMN2HPGDMAPK1HTT
SCHEMBL10226911 0.95 ALOX5 (0.43) ALOX5SMN1; SMN2HPGDMAPK1HTT
SCHEMBL787218 0.94 ALOX5 (0.43) ALOX5SMN1; SMN2HPGDMAPK1HTT
SCHEMBL787214 0.93 AHR (0.42) ALOX5SMN1; SMN2HPGDMAPK1HTT
SCHEMBL787146 0.92 AHR (0.41) ALOX5SMN1; SMN2HPGDMAPK1HTT
SCHEMBL788944 0.89 ALOX5 (0.57) ALOX5SMN1; SMN2HPGDMAPK1HTT
SCHEMBL788870 0.89 ALOX5 (0.57) ALOX5CDK4CCND1PRKDCKDM4E
SCHEMBL788745 0.89 ALOX5 (0.57) ALOX5CDK4CCND1PRKDCKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9450188-B2 Carbazole derivative, light-emitting element material and organic semiconductor material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-09-20 US disclosed
US-20140145175-A1 Carbazole Derivative, Light-Emitting Element Material and Organic Semiconductor Material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-05-29 US disclosed
US-8642782-B2 Carbazole derivative, light-emitting element material and organic semiconductor material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-02-04 US disclosed
US-20120071668-A1 Carbazole Derivative, Light-Emitting Element Material and Organic Semiconductor Material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071668-A1 Carbazole Derivative, Light-Emitting Element Material and Organic Semiconductor Material SLC39A3, SULT1A1, NUTF2 ALOX5 1162/4885SMN1; SMN2 3933/4885HPGD 1834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.